JP2024170583A5 - - Google Patents

Download PDF

Info

Publication number
JP2024170583A5
JP2024170583A5 JP2024154560A JP2024154560A JP2024170583A5 JP 2024170583 A5 JP2024170583 A5 JP 2024170583A5 JP 2024154560 A JP2024154560 A JP 2024154560A JP 2024154560 A JP2024154560 A JP 2024154560A JP 2024170583 A5 JP2024170583 A5 JP 2024170583A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
excipient
nanoparticles
composition according
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024154560A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024170583A (ja
Filing date
Publication date
Priority claimed from JP2021503813A external-priority patent/JP7611813B2/ja
Application filed filed Critical
Publication of JP2024170583A publication Critical patent/JP2024170583A/ja
Publication of JP2024170583A5 publication Critical patent/JP2024170583A5/ja
Pending legal-status Critical Current

Links

JP2024154560A 2018-07-24 2024-09-09 超高速凍結による表面改質された治療活性粒子の組成物 Pending JP2024170583A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862702674P 2018-07-24 2018-07-24
US62/702,674 2018-07-24
JP2021503813A JP7611813B2 (ja) 2018-07-24 2019-07-24 超高速凍結による表面改質された治療活性粒子の組成物
PCT/US2019/043202 WO2020023614A1 (en) 2018-07-24 2019-07-24 Compositions of surface-modified therapeutically active particles by ultra-rapid freezing

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021503813A Division JP7611813B2 (ja) 2018-07-24 2019-07-24 超高速凍結による表面改質された治療活性粒子の組成物

Publications (2)

Publication Number Publication Date
JP2024170583A JP2024170583A (ja) 2024-12-10
JP2024170583A5 true JP2024170583A5 (https=) 2025-04-03

Family

ID=69181152

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021503813A Active JP7611813B2 (ja) 2018-07-24 2019-07-24 超高速凍結による表面改質された治療活性粒子の組成物
JP2024154560A Pending JP2024170583A (ja) 2018-07-24 2024-09-09 超高速凍結による表面改質された治療活性粒子の組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021503813A Active JP7611813B2 (ja) 2018-07-24 2019-07-24 超高速凍結による表面改質された治療活性粒子の組成物

Country Status (12)

Country Link
US (1) US20210338671A1 (https=)
EP (1) EP3827260A4 (https=)
JP (2) JP7611813B2 (https=)
KR (1) KR20210038583A (https=)
CN (1) CN112673257B (https=)
AU (1) AU2019311086A1 (https=)
BR (1) BR112021001290A2 (https=)
CA (1) CA3106618A1 (https=)
EA (1) EA202190331A1 (https=)
IL (1) IL280342A (https=)
MX (1) MX2021000796A (https=)
WO (1) WO2020023614A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014186754A2 (en) 2013-05-16 2014-11-20 Board Of Regents The University Of Texas System Dry solid aluminum adjuvant-containing vaccines and related methods thereof
WO2019118393A1 (en) 2017-12-11 2019-06-20 Board Of Regents, The University Of Texas System Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
CN113398079B (zh) * 2020-03-16 2024-01-19 鲁南制药集团股份有限公司 一种注射用氟达拉滨冻干粉
US12594238B2 (en) 2020-09-03 2026-04-07 Philip Morris Products S.A. Low hygroscopicity active powder compositions
BR112023003114A2 (pt) * 2020-09-03 2023-04-04 Philip Morris Products Sa Composições em pó ativas de baixa higroscopicidade liofilizadas
US11793808B2 (en) 2021-02-22 2023-10-24 Mannkind Corp. Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
CA3211799A1 (en) * 2021-03-12 2022-09-15 Robert O. Williams Iii Methods to prepare dry powders using suspension based thin film freezing
US12015755B2 (en) 2021-03-25 2024-06-18 Korea Advanced Institute Of Science And Technology Real-time omnidirectional stereo matching method using multi-view fisheye lenses and system thereof
CN113484469B (zh) * 2021-06-30 2022-11-18 中国科学院青海盐湖研究所 水合盐体系相变储能材料纳米尺度相分离的原位表征方法
CN116440084A (zh) * 2022-01-07 2023-07-18 浙江萃泽医药科技有限公司 一种可吸入的药物粉末制剂及其制备方法
AU2023366929A1 (en) 2022-10-25 2025-05-08 Veradermics, Incorporated Compositions and methods of use for modified release minoxidil

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08310969A (ja) * 1995-05-22 1996-11-26 Lion Corp 固形薬品組成物及びその製造方法
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
CN1750811A (zh) * 2001-10-19 2006-03-22 巴克斯特国际公司 在冷冻水基质中包括颗粒的稳定组合物
GB0321607D0 (en) * 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
WO2006026502A1 (en) * 2004-08-27 2006-03-09 The Dow Chemical Company Enhanced delivery of drug compositions to treat life threatening infections
WO2007011396A2 (en) 2004-10-29 2007-01-25 President And Fellows Of Harvard College Particles for treatment of pulmonary infection
US8361439B1 (en) * 2005-01-04 2013-01-29 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
EP1954246A4 (en) 2005-11-11 2012-01-18 Biolab Sanus Farmaceutica Ltda SOLID PHARMACEUTICAL COMPOSITION WITH AGGLOMERATE NANOTEILES AND MANUFACTURING METHOD THEREFOR
WO2011046842A1 (en) * 2009-10-12 2011-04-21 The Regents Of The University Of California Targeted nanoclusters and methods of their use
EP2720680B1 (en) * 2011-06-17 2020-02-12 Berg LLC Inhalable pharmaceutical compositions
WO2013132457A2 (en) * 2012-03-07 2013-09-12 National Institute Of Pharmaceutical Education And Research (Niper) Nanocrystalline solid dispersion compositions and process of preparation thereof
JP6940416B2 (ja) 2015-05-01 2021-09-29 ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System 多剤脆性マトリックス組成物

Similar Documents

Publication Publication Date Title
JP2024170583A5 (https=)
JP2023002662A5 (https=)
JP2014518268A5 (https=)
JP2774379B2 (ja) 医薬エアロゾール組成物ならびにそれらのウイルス疾患の治療および予防用途
CN109952101A (zh) 治疗高细胞因子血症和病毒感染的肥大细胞稳定剂
CN111228275A (zh) 一种化合物在制备治疗病毒性肺炎药物中的应用
JP2023520323A5 (https=)
JP2024541569A5 (https=)
JP2024504225A5 (https=)
JP2009521473A5 (https=)
JP2023533162A5 (https=)
JP2022534776A5 (https=)
JP2023520591A5 (https=)
JP2007511539A5 (https=)
WO2001001978A1 (fr) Compositions de medicaments servant a prevenir ou a traiter la myocardite virale
WO2022199049A1 (zh) 乌司他丁在制备治疗新型冠状病毒肺炎药物中的用途
WO2019161761A1 (zh) 一种治疗疟疾的药物组合物
JP2023520703A5 (https=)
JP2023518249A5 (https=)
JP2023525981A5 (https=)
JP2023520929A5 (https=)
FI4199922T3 (fi) (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa
US11497747B2 (en) Compositions and methods for treating lung injuries associated with SARS-CoV-2 infections
JP2024523406A5 (https=)
CN102670684B (zh) 白薇总皂苷的应用